Literature DB >> 10592661

Structure and function of hepatitis C virus NS3 helicase.

A D Kwong1, J L Kim, C Lin.   

Abstract

Hepatitis C Virus helicase activity has been mapped to the COOH-terminal 450 residues of the NS3 protein. Due to its complexity and presumed essentiality for viral replication, the helicase is an attractive target for drug discovery. The elucidation of the atomic structure of the HCV NS3 helicase in complex with oligonucleotide and with ADP has helped clarify our understanding of potential sites for inhibitor binding. Molecular details of the mechanism of this enzyme, and in particular, a better understanding of the mechanism by which ATP hydrolysis is coupled to unwinding of double-stranded substrate may facilitate more efficient structure-based drug design.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10592661     DOI: 10.1007/978-3-642-59605-6_9

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  22 in total

1.  The human coronavirus 229E superfamily 1 helicase has RNA and DNA duplex-unwinding activities with 5'-to-3' polarity.

Authors:  A Seybert; A Hegyi; S G Siddell; J Ziebuhr
Journal:  RNA       Date:  2000-07       Impact factor: 4.942

2.  Single strand binding proteins increase the processivity of DNA unwinding by the hepatitis C virus helicase.

Authors:  Vaishnavi Rajagopal; Smita S Patel
Journal:  J Mol Biol       Date:  2007-11-01       Impact factor: 5.469

3.  Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1.

Authors:  Francois H T Duong; Verena Christen; Jan Martin Berke; Sabina Hernandez Penna; Darius Moradpour; Markus H Heim
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Structure-based mutational analysis of the hepatitis C virus NS3 helicase.

Authors:  C L Tai; W C Pan; S H Liaw; U C Yang; L H Hwang; D S Chen
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  Letter to the editor: Sequence-specific 1H, 15N and 13C resonance assignments for an engineered arginine-rich domain of the hepatitis C virus NS3 RNA helicase.

Authors:  D Liu; D F Wyss
Journal:  J Biomol NMR       Date:  2000-11       Impact factor: 2.835

Review 6.  Helicases as antiviral drug targets.

Authors:  David N Frick
Journal:  Drug News Perspect       Date:  2003 Jul-Aug

7.  Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus.

Authors:  Byounghoon Hwang; Jung Sun Cho; Hyeon Ju Yeo; Jung-Hye Kim; Kyung Min Chung; Kyungsook Han; Sung Key Jang; Seong-Wook Lee
Journal:  RNA       Date:  2004-07-09       Impact factor: 4.942

8.  Secondary structure of the 3' terminus of hepatitis C virus minus-strand RNA.

Authors:  Catherine Schuster; Catherine Isel; Isabelle Imbert; Chantal Ehresmann; Roland Marquet; Marie Paule Kieny
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase.

Authors:  Konstantin A Ivanov; Volker Thiel; Jessika C Dobbe; Yvonne van der Meer; Eric J Snijder; John Ziebuhr
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Two novel conserved motifs in the hepatitis C virus NS3 protein critical for helicase action.

Authors:  Angela M I Lam; David Keeney; David N Frick
Journal:  J Biol Chem       Date:  2003-08-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.